• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动脉-髂动脉支架植入术后 3 年主要不良心血管事件的独立预测因素。

Independent Predictors of Major Adverse Cardiovascular Events at 3 Years after Aortoiliac Stent Implantation.

机构信息

Cardiovascular Center, Takatsu General Hospital, Kanagawa, Japan.

Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

J Vasc Interv Radiol. 2022 Jul;33(7):826-833.e1. doi: 10.1016/j.jvir.2022.03.602. Epub 2022 Apr 7.

DOI:10.1016/j.jvir.2022.03.602
PMID:35398480
Abstract

PURPOSE

To identify the risk factors for major adverse cardiovascular events (MACEs) in real-world practice for symptomatic peripheral artery disease in Japan.

MATERIALS AND METHODS

Data on Japanese patients (N = 880) from the Observational Prospective Multicenter Registry Study on Outcomes of Peripheral Arterial Disease Patients Treated by Angioplasty Therapy for Aortoiliac Artery who underwent de novo aortoiliac stent placement. The 3-year risk of incident MACEs was investigated.

RESULTS

The median age of the patients was 72.6 years (range, 34-97 years), and 83.1% of the patients were men. The patients had the following conditions: smoking (35.6%), hypertension (94.1%), dyslipidemia (81.7%), diabetes (48.0%), renal failure on dialysis (12.6%), myocardial infarction (12.7%), stroke (15.8%), and chronic limb-threatening ischemia (7.1%). Femoropopliteal lesions were present in 38.8% of the limbs with aortoiliac lesions. The 3-year rate of freedom from MACEs was 89.1%. Baseline characteristics, such as age, renal failure on dialysis, myocardial infarction, stroke, and femoropopliteal lesions, were independently associated with the risk of incident MACEs. When the study population was stratified according to these risk factors, the rate of MACEs was highest in patients with at least 3 risk factors (32.9% at 3 years).

CONCLUSIONS

The 3-year rate of freedom from MACEs was reported. Baseline characteristics, such as age, renal failure on dialysis, myocardial infarction, stroke, and femoropopliteal lesions, are independent risk factors for MACEs after aortoiliac stent placement.

摘要

目的

确定日本有症状外周动脉疾病真实世界实践中主要不良心血管事件(MACE)的风险因素。

材料和方法

该研究纳入了接受初次主髂动脉支架置入术的经皮血管成形术治疗的外周动脉疾病患者的观察性前瞻性多中心注册研究中的 880 例日本患者的数据。研究调查了 3 年内发生 MACE 的风险。

结果

患者的中位年龄为 72.6 岁(范围,34-97 岁),83.1%为男性。患者有以下情况:吸烟(35.6%)、高血压(94.1%)、血脂异常(81.7%)、糖尿病(48.0%)、需要透析的肾功能衰竭(12.6%)、心肌梗死(12.7%)、中风(15.8%)和慢性肢体威胁性缺血(7.1%)。主髂动脉病变的肢体中有 38.8%存在股腘病变。3 年无 MACE 发生率为 89.1%。年龄、透析肾功能衰竭、心肌梗死、中风和股腘病变等基线特征与发生 MACE 的风险独立相关。根据这些风险因素对研究人群进行分层时,至少有 3 个危险因素的患者的 MACE 发生率最高(3 年时为 32.9%)。

结论

报告了 3 年无 MACE 发生率。年龄、透析肾功能衰竭、心肌梗死、中风和股腘病变等基线特征是主髂动脉支架置入后 MACE 的独立危险因素。

相似文献

1
Independent Predictors of Major Adverse Cardiovascular Events at 3 Years after Aortoiliac Stent Implantation.主动脉-髂动脉支架植入术后 3 年主要不良心血管事件的独立预测因素。
J Vasc Interv Radiol. 2022 Jul;33(7):826-833.e1. doi: 10.1016/j.jvir.2022.03.602. Epub 2022 Apr 7.
2
Independent predictors of loss of primary patency at 1 year after aortoiliac stent implantation.主-髂动脉支架植入术后1年原发性通畅丧失的独立预测因素。
Heart Vessels. 2020 May;35(5):614-619. doi: 10.1007/s00380-019-01524-9. Epub 2019 Oct 23.
3
Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.在股腘动脉病变的外周动脉疾病患者中,无聚合物、紫杉醇涂层支架与支架移植物的临床结局比较。
J Vasc Surg. 2021 Jun;73(6):1998-2008.e1. doi: 10.1016/j.jvs.2020.12.061. Epub 2021 Jan 5.
4
Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).单纯球囊血管成形术与镍钛诺支架植入术治疗小股腘动脉疾病患者的临床结局:来自股腘动脉支架置入回顾性多中心分析(REAL-FP)的观察结果
Catheter Cardiovasc Interv. 2017 Nov 1;90(5):790-797. doi: 10.1002/ccd.27192. Epub 2017 Jul 19.
5
PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.PEACE I 所有受试者注册研究:4 法国规格的 Pulsar-18 自膨式镍钛合金支架植入股腘动脉病变后的通畅性评估
J Endovasc Ther. 2014 Jun;21(3):373-80. doi: 10.1583/13-4637R.1.
6
Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.血管内超声指导下的血管大小对股腘动脉病变支架植入术后中期结果的影响。
J Endovasc Ther. 2020 Feb;27(1):77-85. doi: 10.1177/1526602819896293.
7
Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.用于股腘动脉病变的药物洗脱支架置入术,随后进行西洛他唑治疗,可降低有症状外周动脉疾病患者的支架再狭窄率。
J Vasc Surg. 2017 Mar;65(3):720-725. doi: 10.1016/j.jvs.2016.10.098. Epub 2017 Jan 7.
8
1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.ZEPHYR 注册研究 1 年结果(用于股浅动脉和腘动脉的 Zilver PTX):再狭窄的预测因素。
JACC Cardiovasc Interv. 2015 Jul;8(8):1105-1112. doi: 10.1016/j.jcin.2015.03.022. Epub 2015 Jun 24.
9
1-Year All-Comers Analysis of the Eluvia Drug-Eluting Stent for Long Femoropopliteal Lesions After Suboptimal Angioplasty.1 年所有入组患者分析:在次优球囊成形术后长段股浅动脉病变中使用 Eluvia 药物洗脱支架。
JACC Cardiovasc Interv. 2018 May 28;11(10):957-966. doi: 10.1016/j.jcin.2018.03.046.
10
Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.药物洗脱支架与经皮腔内血管成形术治疗股腘动脉支架内再狭窄:一项回顾性1年多中心研究的结果
J Endovasc Ther. 2016 Aug;23(4):642-7. doi: 10.1177/1526602816642195. Epub 2016 Apr 20.

引用本文的文献

1
Long-Term and Time-Dependent Association of Predictors on Mortality in Patients With Iliofemoral Artery Disease.髂股动脉疾病患者预测因素与死亡率的长期及时间依赖性关联
JACC Asia. 2025 Sep;5(9):1187-1195. doi: 10.1016/j.jacasi.2025.03.013. Epub 2025 May 27.